Refining colorectal cancer classification and clinical stratification through a single-cell atlas.
Ateeq M KhaliqCihat ErdoganZeyneb KurtSultan Sevgi TurgutMiles W GrunvaldTim RandSonal KhareJeffrey A BorgiaDana M HaydenSam G PappasHenry R GovekarAudrey E KamJochen ReiserKiran TuragaMilan RadovichYong ZangYingjie QiuYunlong LiuMelissa L FishelAnita TurkVineet GuptaRam Al-SabtiJanakiraman SubramanianTimothy M KuzelAnguraj SadanandamLevi WaldronArif HussainMohammad SaleemBassel El-RayesAmeen A SalahudeenAshiq MasoodPublished in: Genome biology (2022)
Distinct CAFs and C1Q+ TAMs are sufficient to explain CMS predictive ability and a simpler signature based on these cellular phenotypes could stratify CRC patient prognosis with greater precision. Therapeutically targeting specific CAF subtypes and C1Q + TAMs may promote immunotherapy responses in CRC patients.